-
IFN-α2b therapy shows promise in patients as potential COVID-19 treatment
europeanpharmaceuticalreview
May 20, 2020
A group of researchers has found that IFN-α2b therapy reduced blood levels of IL-6 and C-reactive protein, two inflammatory proteins found in COVID-19 patients.
-
BioMed X Launches Rapid Antiviral Response Platform
contractpharma
May 14, 2020
Aims to develop ultrafast new antiviral drug discovery, development and mass-manufacturing tools for rapid scale-up of new medications.
-
New triple antiviral drugs combo shows promise against COVID-19: Study
expresspharma
May 11, 2020
Treatment involving a combination of the drugs interferon beta-1b, plus antiviral therapy lopinavir-ritonavir and ribavirin, is better at reducing the viral load.
-
Fujifilm Boosts Production of Avigan Tablet for COVID-19
contractpharma
April 16, 2020
Expands manufacturing capacity at Fujifilm Toyama Chemical to increase production of its influenza antiviral drug.
-
AIkido Pharma Inks Exclusive License for Antiviral Drug Platform
contractpharma
April 15, 2020
Pan-viral inhibitory compound with efficacy against multiple viral pathogens including Influenza, SARS-COV, MERS-COV, Ebola and Marburg virus.
-
University Hospitals among first in nation to test investigational antiviral drug against COVID-19
prnewswire
March 25, 2020
University Hospitals has secured two clinical trials that will provide the investigational antiviral drug remdesivir to hospitalized adults with a pneumonia ...
-
Lasa & ICT explore Favipiravir therapy to fight Covid 19
expresspharma
March 18, 2020
Favipiravir is an antiviral drug and is a promising antidote for the treatment of Coronavirus disease (Covid-19).
-
Which Will Claim the Real "Magic Medicine" Among 3 "Specific Medicines" against Novel Coronavirus Pneumonia
PharmaSources/Mi Ling
February 25, 2020
Challenge Contest of "Specific Medicines" against Novel Coronavirus Pneumonia - Which Will Claim the Real "Magic Medicine" in Such 1/3 Competition?
-
Experimental antiviral Drug Remdesivir recognized as potential treatment for 2019-nCov
PharmaSources
February 10, 2020
Remdesivir, an experimental antiviral drug, has been recognized as a potential treatment against the 2019 novel-Coronavirus (2019-nCov) recently outbreaks in China and around the world.
-
GS-5734 inhibits a range of emerging coronaviruses
europeanpharmaceuticalreview
March 13, 2018
Researchers report on GS-5734, a promising experimental broad-spectrum antiviral drug…